D.E. Shaw & Co’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,200
Closed -$196K 4877
2025
Q3
$196K Buy
+15,200
New +$203K ﹤0.01% 4289
2025
Q1
Sell
-66,700
Closed -$1.99M 4589
2024
Q4
$1.99M Hold
66,700
﹤0.01% 2740
2024
Q3
$1.04M Hold
66,700
﹤0.01% 3245
2024
Q2
$1.14M Buy
66,700
+25,400
+62% +$447K ﹤0.01% 3097
2024
Q1
$646K Buy
+41,300
New +$607K ﹤0.01% 3358
2022
Q2
Sell
-10,000
Closed -$829K 5631
2022
Q1
$829K Sell
10,000
-30,000
-75% -$2.21M ﹤0.01% 4052
2021
Q4
$3M Hold
40,000
﹤0.01% 2954
2021
Q3
$4.65M Buy
40,000
+10,000
+33% +$1.51M ﹤0.01% 2167
2021
Q2
$6.66M Buy
30,000
+20,000
+200% +$3.89M 0.01% 1813
2021
Q1
$1.32M Sell
10,000
-9,500
-49% -$1.5M ﹤0.01% 2900
2020
Q4
$3.37M Buy
+19,500
New +$2.67M ﹤0.01% 2177
2020
Q3
Sell
-19,100
Closed -$1.13M 4052
2020
Q2
$1.13M Sell
19,100
-10,900
-36% -$717K ﹤0.01% 2834
2020
Q1
$2.02M Buy
30,000
+12,600
+72% +$996K ﹤0.01% 2154
2019
Q4
$1.47M Hold
17,400
﹤0.01% 2718
2019
Q3
$1.3M Buy
+17,400
New +$1.39M ﹤0.01% 2669
2019
Q2
Sell
-20,000
Closed -$963K 3800
2019
Q1
$963K Buy
+20,000
New +$963K ﹤0.01% 2629

Other funds holding NVCR